Triethylene Glycol Dimethacrylate in Dental Resins

Triethylene glycol dimethacrylate, almost universally called TEGDMA, is a small, flexible molecule used primarily as a thinning agent in dental composite resins. If you have a tooth-colored filling, a sealant, or certain bonding agents in your mouth, there is a strong chance TEGDMA is part of the formula. Its job is straightforward: it makes the thick, sticky base resin workable enough for a dentist to shape before the curing light hardens it. But TEGDMA comes with real tradeoffs, from polymerization shrinkage to low-level leaching and biological effects that researchers have spent decades trying to understand and mitigate.

What TEGDMA Does in a Dental Filling

Most modern dental composites are built around a high-molecular-weight monomer called BisGMA. BisGMA is excellent at forming a hard, durable polymer network, but on its own it is extremely viscous, far too thick for a dentist to pack into a cavity. TEGDMA solves this problem. It is a low-viscosity monomer that blends with BisGMA to create a paste that flows well and can be mixed with glass or ceramic filler particles. The ratio of BisGMA to TEGDMA in commercial composites typically ranges from about 7:3 to 3:7, depending on the product’s intended handling characteristics and the manufacturer’s performance targets.

TEGDMA does more than just thin the mixture. Because it has two reactive methacrylate groups at either end of a flexible chain, it acts as a crosslinker during polymerization, connecting growing polymer chains to one another and creating a dense three-dimensional network. Research on the physical properties of cured dimethacrylate resins has found that TEGDMA tends to produce the densest polymer network of the common dental monomers, though it is also the most flexible and absorbs the most water.¹ That water uptake is one of the ways the material eventually degrades in the mouth, and it is part of the reason TEGDMA has attracted so much scrutiny.

The Shrinkage Problem

Every resin-based dental composite shrinks when it hardens. The monomers start out loosely arranged and are pulled closer together as they bond into a polymer. This polymerization shrinkage creates stress at the interface between the filling and the tooth, which over time can cause gaps, microleakage, and eventually secondary cavities. TEGDMA makes this problem worse: the more TEGDMA in the formulation, the greater the shrinkage. Studies varying the BisGMA-to-TEGDMA ratio show that the resin composition has a stronger influence on polymerization stress, conversion rate, and overall shrinkage than the amount of filler added to the composite.²

The relationship is not a simple one-to-one trade. TEGDMA-rich formulations also reach a higher degree of conversion, meaning more of the monomer actually polymerizes. That sounds like a good thing, and it is for hardness and wear resistance. But higher conversion also means more shrinkage. Research on experimental composites has found that shrinkage strain rises with increasing TEGDMA concentration more steeply than the degree of conversion does, suggesting the extra shrinkage is not fully explained by the extra curing.³ This is the central materials-science tension around TEGDMA: you want enough to make the composite workable and well-cured, but every bit you add increases the mechanical stress that shortens a filling’s life.

How Unreacted TEGDMA Escapes From Fillings

No dental composite achieves complete conversion. Even under ideal curing conditions, a fraction of the monomer never polymerizes and remains trapped in the hardened network. Over hours and days, some of this unreacted monomer leaches out into saliva or the surrounding tissue. TEGDMA’s small molecular size and relatively hydrophilic character make it particularly prone to this.

In vitro studies measuring monomer release from commercial composites consistently detect TEGDMA eluting from the material. One study of a bulk-fill composite found that most TEGDMA release happened in the first 24 hours, with roughly 5.4 micrograms per gram of material leaching into distilled water during that initial period. In ethanol-based solvents, which simulate fatty foods and accelerate extraction, the total release over 31 days was higher, reaching about 16 micrograms per gram in pure ethanol.⁴ Another study of two conventional composites found that TEGDMA release tapered off by 28 days, while the larger BisGMA monomer continued leaching at higher levels for longer.⁵ Separate work on different bulk-fill products confirmed that both BisGMA and TEGDMA release was detectable and significant across different storage intervals.⁶

These are small amounts, and they are far below the concentrations used in toxicity studies. But the leaching is real, it happens in every patient with a composite filling, and it raises the question of what those escaped monomers do once they are loose in the body.

What Lab Studies Show About TEGDMA Toxicity

Cell culture experiments paint a consistent picture: TEGDMA, at the concentrations achievable in lab dishes, can stress and damage human cells through several pathways. Much of this work has been done on dental pulp cells, the living tissue inside the tooth closest to a filling.

One of the most reliably observed effects is a spike in reactive oxygen species (ROS), the chemically aggressive molecules that cells normally keep in check. Treating human dental pulp cells with TEGDMA increased ROS levels and depleted the cells’ stores of glutathione, their main internal antioxidant.⁷ A separate study identified the enzyme NOX4 as a key player in this process: TEGDMA turned up NOX4 activity in both embryonic palatal cells and dental pulp cells, ramping up ROS production.⁸

The damage extends to the mitochondria, the structures inside cells that generate energy. Dental pulp stem cells exposed to TEGDMA showed a dramatic drop in oxygen consumption when using most energy substrates, falling from around 85–93% of normal to roughly 24–35%. One substrate, succinate, was affected less severely, suggesting TEGDMA targets specific parts of the mitochondrial energy chain rather than shutting everything down indiscriminately.⁹

TEGDMA also causes DNA damage. In macrophages, it produced a dose-related increase in micronuclei and DNA strand breaks, markers of genotoxicity.¹⁰ In human lymphocytes, genotoxic effects were measurable at concentrations as low as 100 micromolar, and chromosome-level abnormalities appeared across all tested doses.¹¹

An important caveat: these are studies on isolated cells bathed directly in TEGDMA solutions, often at concentrations many times higher than what would reach living tissue from a dental filling. Cell culture work is valuable for identifying mechanisms and hazard potential, but it does not directly predict real-world risk to a person with a composite restoration. The gap between the lab dish and the mouth is large.

How the Body Clears TEGDMA

Animal studies in guinea pigs give a surprisingly detailed picture of what happens when TEGDMA enters the bloodstream. After intravenous injection, the monomer or its breakdown products spread broadly through the body: muscle tissue accumulated the largest share (about 7% of the dose), followed by the kidneys (roughly 4%) and skin (about 3%). But TEGDMA did not linger. The body broke it down rapidly, and the dominant route of elimination was exhalation: over 24 hours, about 62% of the administered radioactive-labeled TEGDMA was breathed out as labeled carbon dioxide.¹² Another roughly 15% left through the urine. By 24 hours, the total amount remaining in all organs combined had dropped to under 4% of the original dose.

Follow-up work confirmed that absorption from the gut was fast and distribution was wide, with more than 60% of the dose ultimately exhaled as carbon dioxide and about 20% appearing in urine. The researchers concluded that peak tissue levels of TEGDMA were well below those known to cause toxicity in cell culture.¹³ The conversion to CO₂ suggests the body is breaking TEGDMA apart, likely via ester hydrolysis, and feeding the fragments into normal metabolic pathways. The intermediate metabolites formed along the way are less well characterized and remain a subject of interest, since some may be more reactive than TEGDMA itself.

TEGDMA and Cavity-Causing Bacteria

One of the more unsettling findings about TEGDMA has nothing to do with human cell toxicity. When TEGDMA is broken down in the mouth, one of its products is triethylene glycol (TEG). And TEG, it turns out, makes the primary cavity-causing bacterium more aggressive.

Research exposing Streptococcus mutans to low concentrations of TEG at acidic pH found that several virulence-related genes were significantly upregulated, with expression increases ranging from two- to nine-fold in biofilm cultures compared to controls.¹⁴ The affected genes included those involved in producing glucans, the sticky polymers that help bacteria cling to tooth surfaces and build plaque. In other words, the very material placed in a tooth to treat a cavity could, as it degrades, help create conditions for a new cavity nearby.

This effect is concentration-dependent. At higher concentrations of the intact TEGDMA monomer (around 500 micrograms per milliliter), bacterial metabolic activity was actually reduced, suggesting the monomer itself may be somewhat antimicrobial at those levels.¹⁵ But the concentrations that leak from a filling into the surrounding environment are far lower, placing them squarely in the range where the degradation product TEG promotes bacterial virulence rather than suppressing it. The clinical significance of this is still being studied, but it adds a layer of irony to the use of TEGDMA in restorations.

Degradation in the Mouth Over Time

Beyond monomer leaching, the polymer network itself degrades in the oral environment. Saliva contains esterase enzymes that attack the ester bonds in both BisGMA and TEGDMA, slowly breaking down the surface of the composite. Water sorption accelerates this process by swelling the network and creating pathways for enzymes to penetrate deeper into the material.

Research comparing conventional BisGMA/TEGDMA resins with experimental ether-based formulations found that the ester-linked resins weakened measurably within 16 days under enzymatic and hydrolytic challenge, while the ether-based alternatives showed no degradation under the same conditions.¹⁶ This vulnerability is intrinsic to TEGDMA’s chemical structure: the ester groups that make it easy to polymerize are the same ones that enzymes in saliva can cleave. It is one of the fundamental reasons researchers are working on replacement monomers.

Allergic Reactions and Occupational Exposure

For patients, allergic contact reactions to dental composites are uncommon. For dental professionals who handle uncured resin daily, the picture is different. A study of 32 dental workers with confirmed allergic reactions to acrylic monomers found that TEGDMA, along with HEMA and BisGMA, was among the most common sensitizers. Dental nurses and dentists were the most frequently affected, consistent with their direct contact with uncured composite during placement.¹⁷

Contact allergy rates appear to climb with years of exposure. Among dental students in their third and fourth year of training, about 27% showed positive skin reactions to TEGDMA, and there was notable overlap with sensitivity to formaldehyde, a known degradation product of methacrylate monomers.¹⁸ These reactions typically manifest as contact dermatitis on the hands and fingers, sometimes extending to the face. The practical takeaway is that nitrile gloves (not latex, which TEGDMA can penetrate) and careful handling protocols are essential for anyone working with uncured composite resins regularly.

The Search for Replacements

Given the shrinkage, leaching, degradation, and biological concerns, materials scientists have been trying for years to find a drop-in substitute for TEGDMA. The ideal replacement would match its low viscosity, crosslink effectively, and cure to a similar degree of conversion, all without the ester bonds that invite enzymatic breakdown or the biological effects that make the monomer problematic.

Several approaches are in active development. One line of work has explored urethane-containing monomers and acetylated glycerol dimethacrylate as alternative diluents for dental resins.¹⁹ Another group synthesized monomers derived from catechol, a compound found in nature, as complete TEGDMA replacements in photocurable dental composites.²⁰ And work testing commercially available alternative diluents has found that some replacements actually increased the flexural strength of the resulting composite compared to TEGDMA-based formulations.²¹

None of these alternatives has displaced TEGDMA in mainstream commercial products yet. The barrier is partly inertia: decades of clinical data support the performance of BisGMA/TEGDMA composites, and regulators and manufacturers are understandably cautious about switching to less-proven chemistries. But the trajectory is clear. The dental materials field broadly acknowledges TEGDMA’s limitations and is actively working toward formulations that do not carry the same baggage.

TEGDMA Beyond Dentistry

Although dental composites are by far the largest use case, TEGDMA has found an unexpected role in bioprinting and tissue engineering. Researchers developing printable scaffolds for bone repair found that adding TEGDMA to a gelatin-based composite containing nano-hydroxyapatite dramatically improved printability: the ink became easier to extrude, cured with less energy, and the resulting structures were far stiffer and tougher than those made without it, with mechanical properties improving by at least an order of magnitude. Importantly, the composite remained compatible with mesenchymal stem cells over 24 hours of culture.²²

This application highlights a less-discussed quality of TEGDMA: it is genuinely good at what it does as a crosslinking diluent. The molecule’s flexibility, reactivity, and miscibility with a wide range of other monomers and hydrogels make it useful wherever you need a thin, light-curable liquid that hardens into a stiff network. The biological concerns that matter for a filling sitting in your mouth for a decade are less pressing in a scaffold designed to be gradually resorbed and replaced by native tissue. Context, as always, shapes how we weigh the risks.

Environmental Concerns From Dental Waste

A newer area of investigation looks at what happens when TEGDMA-containing materials enter the environment through dental clinic wastewater. Composite remnants, polishing debris, and curing waste all end up in drainage systems, and recent toxicity testing on zebrafish embryos suggests these materials are not biologically inert once they reach waterways. An experimental composite produced the highest acute toxicity among the dental materials tested, with exposed larvae showing reduced body length and increased rates of edema and blood accumulation.²³ This is early-stage work, and the concentrations used in zebrafish studies are much higher than what would typically be found in treated municipal water. But it points to a blind spot: the environmental fate of resin monomers has received far less attention than their clinical biocompatibility, and that gap is starting to close.

How Curing Conditions Affect How Much TEGDMA Remains Unreacted

One of the most practical levers for reducing TEGDMA leaching is simply curing the composite more thoroughly. The degree of conversion depends on several factors: the intensity and type of curing light, the duration of exposure, and the photoinitiator system embedded in the resin. Research comparing halogen lamps, LEDs, and soft-start curing protocols found complex interactions among these variables. Using a soft-start approach (beginning with lower light intensity and ramping up) combined with the right photoinitiator system could achieve a high degree of conversion within 40 seconds while initially slowing the reaction, a combination that reduces stress buildup.²⁴

The photoinitiator choice also matters. Camphorquinone, the most common initiator in dental composites, works faster initially than alternatives like phenyl propanedione (PPD), but after a full 40-second cure the final conversion levels are similar.²⁵ For patients, the practical implication is simple: a dentist who takes the time to cure each increment of composite fully, with a well-maintained curing light held close to the surface, produces a filling with less residual monomer available to leach. Shortcuts during curing translate directly into more unreacted TEGDMA sitting in the restoration.